As expectations from investors, regulators, customers and financial institutions continue to grow, many companies recognize the importance of nature-related assessment and disclosure. However, implementation remains (…)
The recent IPBES business and biodiversity assessment definitively states that the natural world underpins the whole economy with all sectors directly or indirectly dependent on the goods and service (…)
To support business action on nature, WBCSD has developed a “nature journey funnel” that provides clarity and guidance by mapping the key questions companies encounter at different stages of maturity.
The World Business Council for Sustainable Development (WBCSD), in collaboration with leading pharmaceutical companies and supported by PwC UK, has published the Roadmap to Nature (…)
World Business Council for Sustainable Development (WBCSD) is collaborating with leading companies in the sector, with support from PwC UK, to develop a Roadmap to (…)
WBCSD releases first element of its ambitious effort to advance the harmonization of nature-related metrics used by business.
WBCSD in partnership with GSK is convening the pharma sector including AstraZeneca, Bayer, Novartis, Novo Nordisk, Roche and Takeda, to develop an additional tool to (…)
Urgency mounts to preserve nature amidst plunging wildlife populations and the looming threat of mass extinction. The Kunming-Montreal Global Biodiversity Framework targets a bold reversal by 2030, paralleling the net-zero movement for carbon.
Last December, the world took an important step towards resetting its relationship with nature.
WBCSD’s Roadmaps to Nature Positive provide guidance for all businesses as well as in-depth analysis for four high impact systems on nature